Retail & Wholesale » Retail | China National Accord Medicines Corp.

China National Accord Medicines Corp. B | Cash Flow

Fiscal year is January-December. All values HKD Millions.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
674
843
1,270
1,498
1,334
1,597
Depreciation, Depletion & Amortization
132
142
277
257
207
244
Other Funds
137
2,117
228
181
282
58
Funds from Operations
1,040
1,201
1,689
1,649
1,372
1,783
Changes in Working Capital
440
2,169
145
86
268
28
Net Operating Cash Flow
600
967
1,835
1,735
1,640
1,811
Capital Expenditures
190
431
371
311
236
Sale of Fixed Assets & Businesses
6
2
17
92
19
Purchase/Sale of Investments
-
-
7
25
85
Net Investing Cash Flow
201
432
729
68
567
Cash Dividends Paid - Total
65
82
89
157
163
Issuance/Reduction of Debt, Net
5
942
165
572
62
Net Financing Cash Flow
198
1,093
27
548
384
Net Change in Cash
201
307
1,078
1,119
690
Free Cash Flow
410
1,398
1,464
1,424
1,404
Deferred Taxes & Investment Tax Credit
27
21
2
64
13
-
Net Assets from Acquisitions
17
3
118
26
245
Other Sources
-
-
7,539
1,875
87
Exchange Rate Effect
-
-
-
1
1
Other Uses
-
-
7,791
1,489
107

About China National Accord Medicines

View Profile
Address
Accord Pharmaceutical Building
Shenzhen Guangdong 518029
China
Employees -
Website http://www.szaccord.com.cn
Updated 07/08/2019
China National Accord Medicines Corp. Ltd. engages in the research, development, and consultation services of pharmaceutical packaging materials and pharmaceutical industry products. It operates through the following segments: Group, Pharmaceutical Distribution, and Pharmaceutical Manufacturing. The Group segment engages in investing and managing the business.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.